Johnson & Johnson has begun its phase three trial for a potential coronavirus vaccine, the pharmaceutical company announced Wednesday. Dr. Paul Stoffels, chief scientific officer at Johnson & Johnson, joins "Squawk Box" to discuss the progress of the trial.